Perigon Wealth Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
Perigon Wealth Management's HCAT Position: Q3 2026 in Review
Perigon Wealth Management reduced its Health Catalyst (HCAT) stake by 0% in Q3 2026, selling an estimated $2 and leaving 38,529 shares worth $66.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1443.
Perigon Wealth Management first reported a position in HCAT in Q1 2022 and has held it in 19 quarters since. The position peaked at $471K in Q1 2022. 16 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Perigon Wealth Management held 38,529 shares of Health Catalyst worth $66.7K as of Q3 2026.
- Perigon Wealth Management sold 1 Health Catalyst share in Q3 2026, an estimated $2.
- Health Catalyst made up ﹤0.01% of Perigon Wealth Management's portfolio in Q3 2026, its #1443 holding.
- Perigon Wealth Management first reported a position in Health Catalyst in Q1 2022 and has held it in 19 quarters since.
- Perigon Wealth Management's Health Catalyst position peaked at $471K in Q1 2022.
- 16 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Perigon Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.